The latest Novartis action to shutdown RNAi research based on:
"... the lingering problems associated with delivering these therapies tied to the small number of relevant targets they could shoot for drove the move."
http://www.fiercebiotech.com/story/breaking-novartis-slams-brakes-rnai-development-efforts/2014-04-14
This contrasts with the EET and potential Phenomica progress in which:
- The delivery problem has been completely resolved;
- The targeting problem looks like it can be feasibly addressed; and
- The complex RNA payload against gene expression can be replaced with a simple payload against phenotype expression.
Compare the multiple billion$ directed to RNAi programmes - where Phylogica's tens of million$ actually has produced a significantly more effective platform.
- Forums
- ASX - By Stock
- slamming on the rnai brakes
The latest Novartis action to shutdown RNAi research based...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $816.5M |
Open | High | Low | Value | Volume |
17.5¢ | 17.5¢ | 17.0¢ | $281.8K | 1.643M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 437743 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 133268 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 437743 | 0.165 |
8 | 281418 | 0.160 |
10 | 281634 | 0.155 |
13 | 422533 | 0.150 |
5 | 135572 | 0.145 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 133268 | 1 |
0.175 | 426951 | 8 |
0.180 | 1047462 | 7 |
0.185 | 1312500 | 10 |
0.190 | 552000 | 7 |
Last trade - 16.10pm 01/10/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |
The Watchlist
TON
TRITON MINERALS LTD
Adrian Costello, Executive Director
Adrian Costello
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online